Unconventional Therapeutics
Abstract
This thrust developed unique and unconventional approaches to ensure that soldiers are protected against a wide variety of naturally occurring, indigenous or engineered threats. Emphasis was placed on discovery and development of technologies that allow a rapid response (within weeks) to unanticipated threats, whether naturally encountered emerging diseases or agents from intentional attack, to significantly decrease the time needed to produce candidate vaccine. Additionally, new technologies were developed to allow the rapid, cost-effective manufacture of complex therapeutic proteins such as monoclonal antibodies and vaccine antigens; these technologies reduced the time for biologics manufacture from years (or even decades) to only weeks. Select efforts funded under Unconventional Therapeutics transferred to the Medical Program Element 0602115E, in FY 2012.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2014
- Source ID
- 8d3c3c56c4d41b4ae0ce316740c4eed6